L26/P-490 Clinical impact of autologous platelet-rich plasma instillation on thin endometrium
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A.F. Paula und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does adult autologous platelet-rich plasma (PRP) instillation improve endometrial thickness and reproductive outcomes in women with thin endometrium? Summary answer Autologous PRP instillation was associated with an increase in endometrial thickness in this retrospective study; however, the reproductive outcomes were comparable to the control group. What is known already Thin endometrium seems associated with reduced implantation and lower pregnancy rates in assisted reproductive technology cycles, and no standard treatment reliably improves outcomes. Autologous PRP instillation has gained attention as a minimally invasive strategy to enhance endometrial regeneration due to the high concentration of growth factors. Previous studies report controversial results on the effect of PRP on clinical outcomes. Evidence remains limited, heterogeneous, and largely based on small or non-comparative cohorts, highlighting the need for better-controlled analyses. Study design, size, duration A retrospective cohort study included 280 embryo transfers performed across a multicentre network of fertility clinics in Spain and Italy between January 2020 and January 2024. Eligible women had an endometrial thickness of 3–6.9 mm measured before embryo transfer and a history of two implantation failures. Controls never received PRP, whereas the PRP group underwent intrauterine autologous PRP instillation. Outcomes included endometrial thickness, pregnancy, and live birth rates. Participants/materials, setting, methods The PRP group included 94 embryo transfers performed after receiving autologous intrauterine PRP, while 186 transfers served as controls. Endometrial preparation followed standard hormone replacement protocols. Group comparisons were performed using t-test, chi-square or Fisher’s exact test, and proportion tests. Multivariable logistic regression models were used to assess the association between PRP treatment and reproductive outcomes, considering relevant clinical and embryological variables, including baseline endometrial thickness, PGT-A use, oocyte origin, and embryo morphology. Main results and the role of chance The autologous PRP group presented significantly lower baseline endometrial thickness and more features associated with poorer prognosis compared with controls, including a significantly higher proportion of PGT-A cycles, more embryos transferred, and lower inner cell mass quality. Following intrauterine autologous PRP instillation, this group achieved a significantly greater endometrial thickness than controls (6.65 ± 1 mm vs 6.12 ± 0.65mm, p<0.001), both in absolute terms and relative to each patient’s previous cycle (0.95 ± 0.99 mm vs 0.16 ± 0.77 mm of endometrial increase, p<0.001). Despite these differences, reproductive outcomes of the control group were comparable to those of the autologous PRP group, with similar biochemical pregnancy (49.46% vs 43.62%), and live birth rates (36.76% and 24.47%), with no statistically significant differences observed. In multivariate analysis including several confounders, live birth rate was mainly influenced by embryological factors, particularly oocyte origin (aOR 2.39, 95% CI 1.08-5.40, p=0.03), rather than by PRP treatment (aOR 0.56; 95% CI 0.30–1.05; p=0.07). Limitations, reasons for caution The retrospective design and baseline differences between groups limit causal interpretation. Variability in PRP administration, including differences in the timing of intrauterine instillation, PRP volume infused, as well as heterogeneity in endometrial preparation protocols across centres, may have influenced the observed outcomes Wider implications of the findings Autologous PRP instillation increased endometrial thickness in women with thin endometrium, supporting a possible role as a promising adjunct to optimize endometrial development in assisted reproduction. While reproductive success remains strongly influenced by embryo-related factors, PRP may enhance uterine receptivity and contribute to improved outcomes in carefully selected patients. Trial registration number No
Zitieren
APA
Paula, A., Francés-Herrero, E., Agustina-Hernández, M., Corpas, N., Bueno-Fernandez, C., Faus, A., Garijo, L., Castells, I., García-Velasco, J., Cervelló, I., & Cozzolino, M. (2026). L26/P-490 Clinical impact of autologous platelet-rich plasma instillation on thin endometrium. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.823
Vancouver
Paula A, Francés-Herrero E, Agustina-Hernández M, Corpas N, Bueno-Fernandez C, Faus A, et al. L26/P-490 Clinical impact of autologous platelet-rich plasma instillation on thin endometrium. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.823
BibTeX
@article{Paula2026,
author = {Paula, A.F. and Francés-Herrero, E. and Agustina-Hernández, M. and Corpas, N. and Bueno-Fernandez, C. and Faus, A. and Garijo, L. and Castells, I. and García-Velasco, J.A. and Cervelló, I. and Cozzolino, M.},
title = {L26/P-490 Clinical impact of autologous platelet-rich plasma instillation on thin endometrium},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.823}
}
EUVIMED